Paul Tredwell, vice president for specialty brands at Accord Healthcare says innovation is vital for success in today’s generics and biosimilars market.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.